Requirement for receptor‐bound urokinase in plasmin‐dependent cellular conversion of latent TGF‐β to TGF‐β

Journal of Cellular Physiology

Volumn 158, Issue 3, 1994, Pages 398-407

  Odekon, Lale E ^a,c,e   Blasi, Francesco ^a,d,e   Rifkin, Daniel B ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c ALBANY MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF MILAN   (Italy)

^e Beverly Sackler Foundation Laboratory ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE 6 PHOSPHATE; PLASMINOGEN; PLASMINOGEN ACTIVATOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA DERIVATIVE; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; COW; LUNG ALVEOLUS EPITHELIUM; MINK; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANIMAL; CATTLE; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DNA; ENDOTHELIUM, VASCULAR; EPITHELIAL CELLS; EPITHELIUM; FIBRIN; LUNG; MANNOSEPHOSPHATES; MICE; MINK; PLASMIN; RECEPTORS, CELL SURFACE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; URINARY PLASMINOGEN ACTIVATOR;

ANIMALIA; MUSTELA VISON;

EID: 0028268212     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.1041580303     Document Type: Article

References (45)

1. Membrane‐anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds to transforming growth factor‐β
2. An activated form of transforming growth factor‐β is produced by cocultures of endothelial cells and pericytes
3. Transforming growth factor‐beta in human platelets
4. Expression and secretion of type β transforming growth factor by activated human macrophages
5. Accelerated healing of ulcer wounds in the rabbit ear by recombinant human transforming growth factor‐β
6. Immunodetection and quantitation of the two forms of transforming growth factor‐beta (TGF‐β and TGF‐β) secreted by cells in culture
7. Cellular activation of latent transforming growth factor‐β requires binding to cation‐independent mannose‐6‐phosphate/insulin‐like growth factor type II receptor
8. Human transforming growth factor‐β complementary DNA sequence and expression in normal and transformed cells
9. Inhibition of receptor‐bound urokinase by plasminogen‐activator inhibitors
10. Regulation of plasminogen receptor expression on human monocytes and monocytoid cell lines
11. Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells
12. Basic FGF‐induced activation of latent TGF‐β in endothelial cells: Regulation of plasminogen activator activity
13. Characterization of a membrane receptor for transforming growth factor‐β in normal rat kidney fibroblasts
14. Identification and characterization of cells deficient in the mannose‐6‐phosphate receptor: Evidence for alternate pathway for enzyme targeting
15. Plasminogen activator and collagenase production by capillary endothelial cells
16. Binding of plasminogen to cultured human endothelial cells
17. Human transforming growth factor β‐α2‐macroglobulin complex is a latent form of transforming growth factor β
18. Lipoprotein (a) inhibits the generation of transforming growth factor‐β: An endogenous inhibitor of smooth muscle cell migration
19. Mechanism of retinoid‐induced activation of transforming growth factor‐beta in bovine endothelial cells
20. Interactions of recombinant and platelet transforming growth factor‐β1 precursor with the insulin‐like growth factor II/mannose‐6‐phosphate receptor
21. Normal embryo fibroblasts release transforming growth factors in a latent form
22. Conversion of a high molecular weight latent β‐TGF from chicken embryo fibroblasts into a low molecular weight active β‐TGF under acidic conditions
23. Proteolytic activation of latent transforming growth factor‐β from fibroblast conditioned medium
24. Mechanism of activation of latent recombinant transforming growth factor‐β1 by plasmin
25. Cellular receptors for type β transforming growth factor. Ligand binding and affinity labelling in human and rodent cell lines
26. Growth factors are released by mechanically wounded endothelial cells
27. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor
28. Binding of insulin‐like growth factor II (IGF‐II) by human cation‐independent mannose‐6‐phosphate receptor/IGF II‐receptor expressed in receptor‐deficient mouse L cells
29. Latent transforming growth factor‐β in serum: A specific complex with α2‐macroglobulin
30. Urokinase‐type plasminogen activator mediates basic fibroblast growth factor‐induced bovine endothelial cell migration independent of its proteolytic activity
31. In vivo paracrine interaction between urokinase and its receptor: Effect on tumor cell invasion
32. Dog mastocytoma cells produce transforming growth factor‐β
33. Stimulation of rat endothelial cell transforming growth factor‐β production by bleomycin
34. Identification of mannose‐6‐phosphate in two asparagine‐linked sugar chains of recombinant transforming growth factor‐β precursor
35. Complementation analysis of extracellular matrix degeneration: Enhancement of urokinase plasminogen activation by the urokinase receptor
36. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell‐surface plasmin‐dependent proteolysis
37. Inhibition of endothelial cell movement by pericytes and smooth music cells: Activation of a latent transforming growth factor‐β1: like molecule by plasmin during co‐culture
38. Characterization of the activation of latent TGF‐β by co‐cultures of endothelial cells and pericytes or smooth muscle cells: A self‐regulating system
39. 2‐macroglobulin restricts plasminogen activation to the surface of RC2A leukemia cells
40. Activation of pro‐urokinase and plasminogen on human sarcoma cells: A proteolytic system with surface‐bound reactants
41. 125I‐labelled type β transforming growth factor from human platelets
42. Differential expression of TGF‐β isoforms by human articular chondrocytes in response to growth factors
43. Inhibition of low‐density lipoprotein uptake in confluent endothelial cell monolayers correlates with a restricted surface receptor redistribution
44. Characterization of a latent form of transforming growth factor‐beta secreted by human platelets
45. Distribution and modulation of cellular receptor for transforming growth factor‐beta